Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Journal of Thrombosis and Haemostasis : JTH|December 16, 2023
Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopeniaJingyao Ma, Chang Cui, Yongqiang Tang, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 15, 2024
Plasticizer Design Principle of "Like Dissolves Like": Semiconductor Fluid Plasticized Stretchable Fully π-Conjugated Polymers Films for Uniform Large-Area and Flexible Deep-Blue Polymer Light-Emitting DiodesJingyao Ma, Man Xu, Zhiqiang Zhuo, et al.
Research and Practice in Thrombosis and Haemostasis|April 1, 2025
Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from ChinaLingling Fu, Xi Lin, Zhenping Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 2, 2026
Morphology-Controlled Ionic-Electronic Coupling in PEDOT:PSS Enabled by Substituent Engineering of A-Type GridsYang Li, Haodi Zhu, Zheng Zhang, et al.
Chemical Society Reviews|February 27, 2024
Flexible molecular crystals for optoelectronic applicationsChuanxin Wei, Liang Li, Yingying Zheng, et al.
Food & Function|June 6, 2019
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the novel peptide EZY-1 purified from EucheumaHuajun Yu, Zhao Zhang, Hui Huang, et al.
Materials Science & Engineering. C, Materials for Biological Applications|April 2, 2020
The electrostimulation and scar inhibition effect of chitosan/oxidized hydroxyethyl cellulose/reduced graphene oxide/asiaticoside liposome based hydrogel on peripheral nerve regeneration in vitroFurong Zheng, Rui Li, Qundi He, et al.
Annals of Hematology|September 11, 2025
Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITPJingjing Liu, Zhifa Wang, Nan Wang, et al.
Chemical Biology & Drug Design|May 21, 2019
The inhibitory effect of tachyplesin I on thrombosis and its mechanismsHuimin Li, Bin Liu, Jun Wu, et al.
British Journal of Haematology|September 13, 2024
Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trialJingyao Ma, Xiaoli Zhang, Libo Zhao, et al.
Pageof 9